YOLFTbeta
00

Daewon Pharmaceutical Co. Ltd.

003220 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

7,810.00KRW-10.00 (-0.13%)

Price History

Full chart

Market Stats

Previous Close7,820.00
Open7,830.00
Day Range7,740.00 – 7,910.00
52-Week Range7,060.00 – 13,670.00
Volume44.85K
Market Cap168.68B
P/E (TTM)0.00
Forward P/E13.97
Dividend Yield3.17%
Beta0.15
50-Day Avg7,840.20
200-Day Avg9,744.25

About

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Seung-Ryel Baek
  • Employees1.24K
  • Headquarters386 Cheonhodae-ro, Seoul, South Korea, Korea
  • Websitehttps://www.daewonpharm.com

Leadership

  • Mr. Seung-Ryel BaekVice Chairman & CEO · b. 1959
  • Jonathan In BaekCEO, President & Director
  • Mr. Seil SonManaging Director · b. 1968
  • Mr. KyungJun LeeManaging Director · b. 1965

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue138.87B138.17B158.88B181.98B216.19B240.72B265.46B286.65B317.83B308.50B354.18B478.88B526.95B598.16B605.43B
Growth (%)--0.51%+14.99%+14.54%+18.79%+11.35%+10.28%+7.98%+10.88%-2.93%+14.81%+35.21%+10.04%+13.51%+1.22%
Cost of Revenue58.94B62.78B70.80B78.34B100.48B103.21B113.42B121.16B137.67B142.56B177.71B240.94B269.70B310.83B332.65B
Gross Profit--83.78B98.93B115.71B137.51B152.04B165.49B180.16B165.94B176.47B237.94B257.25B287.33B272.79B
Gross Margin--52.73%54.36%53.52%57.13%57.28%57.73%56.68%53.79%49.82%49.69%48.82%48.04%45.06%
Operating Expense--68.23B81.12B92.90B108.37B126.75B134.74B145.05B141.84B157.04B194.94B225.01B259.11B269.28B
Operating Income14.07B13.50B15.54B17.81B22.81B29.15B25.29B30.75B35.11B24.10B19.43B43.01B32.23B28.22B3.51B
Operating Margin10.13%9.77%9.78%9.78%10.55%12.11%9.53%10.73%11.05%7.81%5.48%8.98%6.12%4.72%0.58%
EBITDA------32.37B41.70B47.45B40.50B37.02B61.77B48.01B45.56B33.51B
EBITDA Margin------12.20%14.55%14.93%13.13%10.45%12.90%9.11%7.62%5.54%
Net Income9.44B9.61B12.32B15.73B17.69B20.24B10.74B23.74B27.29B17.64B6.99B31.94B23.92B14.21B-1.38B
Net Income Margin6.79%6.96%7.75%8.64%8.19%8.41%4.05%8.28%8.59%5.72%1.97%6.67%4.54%2.38%-0.23%
R&D5.68B-9.80B10.04B6.44B6.63B6.76B9.28B10.24B13.48B12.60B12.65B18.21B21.93B23.76B
R&D as % of Total Revenue4.09%-6.17%5.52%2.98%2.76%2.55%3.24%3.22%4.37%3.56%2.64%3.46%3.67%3.92%
Interest Expense000000089.41M268.57M1.18B2.08B3.68B4.61B9.31B7.22B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.03%0.08%0.38%0.59%0.77%0.88%1.56%1.19%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets140.39B147.13B160.14B180.62B194.75B214.68B227.20B275.44B327.53B335.21B429.58B453.55B508.00B583.39B613.65B
Total Liabilities36.47B34.20B36.89B46.11B46.09B52.67B59.07B92.24B123.32B122.44B211.18B204.78B243.73B298.81B339.07B
Total Equity103.73B112.39B122.51B133.90B148.19B161.40B167.99B183.51B204.94B213.94B219.30B250.95B266.20B275.28B265.92B
Cash17.61B24.02B19.03B21.27B19.12B13.98B3.68B14.89B13.00B10.44B41.70B26.97B29.98B17.06B47.20B
Net Debt------6.32B13.11B37.00B39.56B79.29B87.20B114.05B165.52B150.89B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow17.93B13.83B12.32B17.45B25.82B20.79B4.27B40.03B30.97B24.95B22.41B33.33B51.73B30.04B42.31B
Investing Cash Flow---16.80B-13.93B-22.70B-20.16B-19.84B-41.73B-47.68B-14.89B-41.62B----
Financing Cash Flow---509.37M-1.27B-5.28B-5.77B5.26B12.90B14.82B-12.58B48.53B----
Capital Expenditure10.19B3.30B9.85B15.84B19.80B20.57B14.71B40.82B33.03B11.35B4.10B13.37B20.61B53.58B42.13B
Free Cash Flow-------13.46B-2.55B-5.68B9.17B10.71B19.96B31.12B-23.55B181.86M
Dividends Paid2.46B637.89M701.67M1.16B2.43B3.40B4.52B4.66B4.89B5.03B3.14B4.12B7.34B6.36B6.43B
FCF to OCF-------315.50%-6.37%-18.34%36.74%47.77%59.90%60.16%-78.40%0.43%
Dividend Paid to FCF-------33.60%-182.61%-86.05%54.92%29.33%20.64%23.58%-27.00%3535.75%

Earnings

Report DateJun 3, 2009Sep 2, 2009Dec 2, 2009Mar 3, 2010Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 27, 2014Nov 28, 2014Mar 20, 2015May 15, 2015Aug 13, 2015Nov 13, 2015Feb 18, 2016May 11, 2016Aug 12, 2016Nov 10, 2016Mar 15, 2017May 11, 2017Aug 10, 2017Nov 13, 2017Feb 14, 2018May 14, 2018Aug 13, 2018Nov 14, 2018Feb 11, 2019May 14, 2019Aug 13, 2019Nov 13, 2019Mar 12, 2020May 15, 2020Aug 14, 2020Nov 13, 2020Feb 4, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Feb 10, 2022May 15, 2022Aug 15, 2022Nov 10, 2022Feb 8, 2023May 15, 2023Aug 11, 2023Nov 13, 2023Mar 14, 2024May 16, 2024Aug 14, 2024Nov 14, 2024Feb 7, 2025May 15, 2025Jun 30, 2025Nov 12, 2025Dec 31, 2025May 13, 2026Jun 30, 2026
EPS Estimate--------------------254.50254.05--392.97288.95281.55427.18302.53222.92381.28355.36261.10-----------------401.97401.00403.73428.46568.73356.49253.44581.65-----
EPS Actual115.35143.36135.87130.7938.2974.75109.01105.03158.5689.96170.21145.00166.77103.95140.42244.62234.15175.57246.62146.12313.59206.51199.55333.11275.54165.51-111.88459.5543.99339.33270.52256.39333.01278.32304.21299.62423.81344.89210.82161.81106.31-380.58143.69295.15270.87495.00341.84522.18141.40449.71385.00252.0023.00436.00-36.00313.00-49.46250.00-139.23-812.50634.38111.53183.75
Surprise--------------------23.22%-18.71%---29.88%-42.72%-139.74%7.58%-85.46%52.22%-29.05%-27.85%27.54%------------------4.22%-37.16%-94.30%1.76%-106.33%-12.20%-119.52%-57.02%-----
Timing--------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-Pre-market-

Key Statistics & Ratios

Market Cap168.68B
Enterprise Value291.22B
Trailing P/E0.00
Forward P/E13.97
PEG Ratio0.00
Price / Sales0.27
Price / Book0.63
Revenue (TTM)614.64B
Gross Profit (TTM)279.55B
EBITDA24.50B
Profit Margin0.43%
Operating Margin0.03%
Return on Equity0.83%
Return on Assets-0.01%
Shares Outstanding21.43M
Shares Float12.98M
Beta0.15
Dividend Yield3.17%
Dividend Rate250.00
Payout Ratio2.13%

Dividends

20251×
250.00Dec 29, 2025
20241×
300.00Dec 27, 2024
20231×
300.00Dec 27, 2023
20221×
350.00Dec 28, 2022
20211×
194.17Dec 29, 2021
20201×
147.94Dec 29, 2020
20191×
233.40Dec 27, 2019
20181×
226.61Dec 27, 2018
20171×
215.82Dec 27, 2017
20161×
209.53Dec 28, 2016
20151×
156.48Dec 29, 2015
20141×
111.77Dec 29, 2014
20131×
53.23Dec 27, 2013
20121×
32.26Dec 27, 2012
20111×
32.26Dec 28, 2011
20101×
114.37Dec 29, 2010
20091×
105.57Dec 29, 2009
20081×
82.11Dec 29, 2008
20071×
82.11Dec 27, 2007
20061×
61.58Dec 27, 2006
20051×
38.12Dec 28, 2005
20041×
29.33Dec 29, 2004
20031×
35.19Dec 29, 2003
20021×
36.31Dec 27, 2002

Stock Splits

  • Mar 7, 20221.03:1
  • Feb 18, 20211.05:1
  • Feb 17, 20201.03:1
  • Feb 11, 20191.03:1
  • Feb 19, 20181.05:1
  • Feb 7, 20171.03:1
  • Feb 18, 20161.03:1
  • Mar 2, 20151.05:1
  • Jan 28, 20141.05:1
  • Jan 31, 20131.1:1
  • Dec 28, 20111.1:1
  • Dec 24, 20072:1